Your email has been successfully added to our mailing list.

×
0 0.00202020202020198 -6.06060606060988E-05 -0.0101010101010101 -0.00606060606060593 -0.0232323232323233 -0.012121212121212 0.0212121212121213
Stock impact report

Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More [Yahoo! Finance]

Sage Therapeutics, Inc. (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
Company Research Source: Yahoo! Finance
Among these, Sage Therapeutics, Inc . SAGE and Incyte INCY were in focus this week as investors were disappointed with study failures. Recap of the Week's Most Important Stories Sage Therapeutics announced disppointing top-line results from the mid-stage study on dalzanemdor (SAGE-718). The phase II DIMENSION Study was a 12-week, double-blind, placebo-controlled study to evaluate the effects of dalzanemdor in participants with cognitive impairment (CI) associated with Huntington's Disease (“HD”). A total of 189 participants were randomized. However, the study did not demonstrate a statistically significant difference from baseline in participants treated with dalzanemdor versus placebo on the Symbol Digit Modalities Test (“SDMT”), a measure of cognitive function, at day 84, the primary endpoint. In addition, analyses of secondary endpoints did not demonstrate statistically significant or clinically meaningful differences in participants treated with dalzanemdor compared to pla Show less Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SAGE alerts
Opt-in for
SAGE alerts

from News Quantified
Opt-in for
SAGE alerts

from News Quantified